Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus spinal cord injury

Fabrisia Ambrosio, Michael L. Boninger, Shirley G. Fitzgerald, Sandra Hubbard, Steven R. Schwid, Rory A. CooperThe Journal of Rehabilitation Research and Development 2007 · DOI

TL;DR

This study reveals a significant disparity in the types of mobility devices issued by the Department of Veterans Affairs (VA) to veterans with Multiple Sclerosis (MS) compared to those with Spinal Cord Injury (SCI). Veterans with MS are less likely to receive higher-quality manual or power wheelchairs, suggesting a potential mismatch between prescribed devices and their functional needs.

What Problem Does This Paper Address?

Individuals with mobility impairments rely heavily on assistive technology (AT) to maintain their independence and quality of life. However, the effectiveness of AT is contingent on a good match between the user's needs and the device's capabilities. Previous research has indicated that individuals with Multiple Sclerosis (MS) report lower satisfaction with their mobility devices compared to those with Spinal Cord Injury (SCI). This discrepancy raises questions about whether the prescription process for mobility devices differs between these two populations, potentially leading to less appropriate device selection for individuals with MS. The authors aim to investigate these differences within the VA system, specifically comparing veterans with MS (V-MS) and veterans with SCI (V-SCI).

Methods

The researchers employed a retrospective study design, analyzing data from two VA databases: the National Patient Care Database (NPCD) and the National Prosthetics Patient Database (NPPD) for the years 2000 and 2001. These databases were merged to create a unique dataset of veterans diagnosed with either MS or SCI who received a wheelchair. Demographic information (age, sex, race/ethnicity) and details about the type of wheelchair issued were extracted. A ranking system of eight wheelchair classes, based on Medicare K-codes, was used to categorize wheelchair quality (function, weight, adjustability). Statistical analyses included descriptive statistics, independent samples t-tests for age comparison, and chi-square analyses to compare demographic distributions and device types between the V-MS and V-SCI groups. A significance level of p < 0.001 was used due to the large sample size.

Datasets

  • National Patient Care Database (NPCD): Used to obtain demographic information (date of birth, sex, race/ethnicity, primary diagnosis).
  • National Prosthetics Patient Database (NPPD): Used to obtain information on assistive devices issued, including wheelchair type and creation date.

These databases were merged to create a comprehensive dataset for the study. No new benchmarks were introduced; the study utilized existing VA administrative data.

Key Insights and Ideas

  • Disparate Device Allocation: The most striking insight is the clear difference in the quality and type of wheelchairs issued to V-MS versus V-SCI. This suggests that the underlying assumptions or clinical decision-making processes for prescribing mobility devices may differ significantly between these two diagnostic groups within the VA.
  • MS and Lower-Quality Devices: Veterans with MS are significantly less likely to receive higher-quality manual or power wheelchairs. This is particularly concerning given the nature of MS, which can involve fatigue and progressive mobility limitations.
  • Scooters as a Common Solution for MS: A disproportionately high number of V-MS received scooters compared to V-SCI. While scooters can be beneficial for some, they may not be suitable for all MS patients and might not address the long-term mobility needs as effectively as a more advanced wheelchair.
  • Potential Mismatch with Functional Needs: The findings raise a critical question: are the prescribed devices truly meeting the functional needs of veterans with MS, especially considering the progressive and often unpredictable nature of the disease? The study implies that a "one-size-fits-all" approach or assumptions about disease progression might be leading to suboptimal device selection.

Key Results

  • Demographics: While the average age of V-MS and V-SCI was statistically different, the difference was not considered clinically significant. The majority of both groups were male, consistent with the overall veteran population. A significant difference in racial/ethnic distribution was observed, with V-MS being more likely to be white.
  • Device Distribution:
    • V-SCI: Received a relatively even distribution of manual (49.8%) and power wheelchairs (43.7%), with scooters being least common (6.4%).
  • V-MS: Manual wheelchairs were the most common (44.7%), followed by power wheelchairs (33.7%), and a substantial proportion received scooters (21.6%).
  • Manual Wheelchair Quality: V-SCI were more likely to receive ultralightweight manual wheelchairs (42.4%), considered higher quality. In contrast, only 14.0% of V-MS received ultralightweight chairs, with a higher proportion receiving depot (39.2%) or lightweight chairs.
  • Power Wheelchair Quality: For V-SCI, custom power wheelchairs were most common (36.3%). For V-MS, nonprogrammable power wheelchairs were more frequent (25.1%), and significantly fewer received custom power wheelchairs (15.5%).

Limitations and Future Work

  • Lack of Data on Disease Progression and Functional Limitations: The study acknowledges a significant limitation in not having data on disease progression, duration, or the specific functional limitations of the veterans. This makes it difficult to definitively link device prescription to individual needs.
  • No Data on Satisfaction: The study did not include data on user satisfaction with the prescribed devices, which was a motivating factor for the research.
  • Geographic Distribution: Potential selection bias due to geographic distribution of veterans with missing data was not fully addressed.
  • Underrepresentation of Tetraplegia: The analysis may have underestimated the number of power wheelchairs issued to V-SCI due to potential underrepresentation of tetraplegia cases in the dataset.
  • Future Work: The authors suggest further investigation into the quality and type of wheeled mobility devices issued to V-MS, focusing on effective solutions for optimizing AT provision and correlating it with AT satisfaction. They also recommend identifying standards of care for prescribing mobility devices for individuals with MS, given their complex and unpredictable disease course. Future studies should also explore the transition from manual to power mobility for V-MS and the role of expert clinician prescription.

Summary updated

Abstract

Individuals with multiple sclerosis (MS) report decreased satisfaction with their mobility devices compared with individuals with spinal cord injuries (SCIs). This study (1) investigated the demographic differences between veterans with MS (V-MS) and veterans with SCI (V-SCI) who were issued a wheelchair by the Veterans Health Administration (VHA) and (2) described differences in mobility device prescription. We merged two VHA databases to obtain demographic and wheelchair information for all V-MS and V-SCI in 2000 and 2001. Descriptive information for issued wheelchairs was available for 2,154 V-MS and V-SCI. We found that V-MS were significantly less likely to receive higher quality wheelchairs (manual or power) compared with V-SCI (p < 0.001). The disparity in VHA wheelchair prescription between these two groups indicates a need for further research regarding the assistive device prescription process in these populations.
BibTeX
@article{ambrosio2007comparison,
  author = {Fabrisia Ambrosio and Michael L. Boninger and Shirley G. Fitzgerald and Sandra Hubbard and Steven R. Schwid and Rory A. Cooper},
  title = {{Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus spinal cord injury}},
  journal = {The Journal of Rehabilitation Research and Development},
  year = {2007},
  doi = {10.1682/jrrd.2006.02.0016},
}
Figure